Enovachem Pharmaceuticals is a pharmaceutical manufacturing, packaging, and repackaging company that has positioned itself as the leader in contract packaging and repackaging services for a diverse range of clients, including physicians, pharmacies, manufacturers, wholesalers, and distributors. Founded in 2009 and headquartered in the United States, Enovachem boasts of being cGMP and CFR Compliant, FDA and DEA Registered Manufacturer, and State Board of Pharmacy Licensed, ensuring compliance with regulatory standards. The company's services span across various sectors, including OTC, supplements, cosmetics, prescription drugs, and controlled substances (C-III – C-V). Notably, Enovachem Pharmaceuticals was acquired by Novatim Equity Partners in 2014. Overall, Enovachem Pharmaceuticals has carved out a prominent position in the manufacturing and pharmaceutical industries, demonstrating its commitment to quality and adherence to regulations. Although specific details about the most recent investment are not available, the company's alliance with Novatim Equity Partners serves as a testament to its potential for growth and innovation. This partnership signifies a strategic move that could catalyze Enovachem's expansion and enhance its competitive edge within the industry.
There is no investment information
No recent news or press coverage available for Enovachem Pharmaceuticals.